ASH 2015: Emerging Combination Treatment Approaches Dr. Andrew Zelenetz of Memorial Sloan Kettering Cancer Center describes the expanding CLL and lymphoma armamentarium on location at the 2015 American Society of Hematology (ASH). Dr. Zelenetz and Carol Preston discuss the results of an international study—designed to improve the current standard of care—that is now leading to a wealth of treatment choices. Says Dr. Zelenetz, “We have the tools now to treat CLL in such a way that we can get deep remissions.” Sponsored by the Patient Empowerment Network through educational grants from Teva and Pharmacyclics. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |